Formulation and evaluation of metronidazole lozenges for oral thrush

Authors

  • Siham Abdoun A. Pharmaceutics Department, College of Pharmacy, Qassim University, KSA
  • Reem Alenizi Pharm D, College of Pharmacy, Qassim University, KSA

DOI:

https://doi.org/10.56511/JIPBS.2019.v6.i03.pp05-10

Abstract

Background: Metronidazole is an antimicrobial medication used for the treatment of a variety of parasitic and bacterial infections of the vagina, gynecological area, skin, intra-abdominal cavity, blood, bone, joint, nervous system, and heart. Metronidazole are market as tablet, capsule, cream, lotion, gel, and injection dosage form but still there is a need for new dosage forms which acts effectively and locally. The lozenges dosage forms will increase bioavailability, reducing gastric irritation and increase onset of action. Preparing lozenges dosage forms will provide suitable choice for geriatric and pediatric patients who can’t swallow tablets formulation. Objective: This study aimed to formulate metronidazole as lozenges to improve delivery of drug to treat oral thrush. Methods: Lozenges were formulated using heating and congealing technique. Chocolate, Cherry and Eudragit E100 were used to mask bitter taste of metronidazole. Quality control tests were done to assess the formulated lozenges physically and chemically. Results: The quality control results revealed that the formulated lozenges had good quality as the content of metronidazole in lozenges was found 100.25± 0.25, their average weight (4.3g ± 0.19), while the mean thickness and diameter of lozenges were (5.29 mm ± 0.23) and (25.24 mm ± 0.18) respectively. The in-vitro drug release of MTZ-Chocolate and MTZ- Cherry show rapid release (86.92% & 82.5%) respectively in 10minute, while MTZ-Eudrigit show slow release 106.43% in 50 minutes. FTIR Spectral study revealed compatibility of MTZ with eudragit and other excipient. Conclusion: The moulded lozenges can provide an attractive alternative formulation of metronidazole medicament for oral thrush

Keywords:

Metronidazole, Lozenges, Oral thrush, In-vitro release, Eudragit

Downloads

Download data is not yet available.

References

Ritschel WA, Kearns GL. Handb ook of Basic Pharmacokinetics: I ncluding clinical applications 6th ed. Washington, DC: American Pharmacists Association, 2004.

Linda A. Felton, Oral Solid Dosage Forms. Remington essential of pharmaceutics. Lambeth High Street, London SE1 7JN, U K: Pharmaceutical Press; 2012; 581

Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. 3. Chapman Hall/CRC Press, Taylor & Francis; New York, New York, USA: 2008.

Griffin, J. P. The Textbook of Pharmaceutical Medicine (6 th ed.). Jersey: BMJ Books. ISBN 978-1-4051-8035-1 , 2009.

Susan M Pond, Tozer, Thomas N. "First - Pass Elimination”, Clinical Pharmacokinetics. 1984; 9 (1): 1 – 25 .

Umashankar M S, Dinesh S R, Rini R, Lakshmi K S, Damodharan N: Chewabl e Lozenge Formulation - A Review. Int . Res. J. Pharm. 2016; 7 (4): 9 - 16.

Nagoba Shivappa N, Purushotham Rao K, Zakaullah S. Formulation of Clotrimazole as lozenge tablet for improved delivery to oral thrush. J ournal of Pharmaceutical and Biomedical Sciences (JPBMS) 2011; 12(12):1 - 4.

Stephen O. Majekodunmi. A review on lozenges. American Journal o f Medicine and Medical Sciences 2015; 5(2):99 - 104.

Ra kesh H., Mohit T. and Kiran K. A Review on Oral Mucosal Drug Delivery System, The Pharma Innova tion 1(1) : 2012; 15.

James C.M. and Carmel M.H. Drug Delivery: Buccal Route, in: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology: 3 th edition, New York, 2007.

Sonja L. Charlotta E. and Carl E. N. Metronidazole is Still the Drug of Choice for Treatment of Anaerobic Infections Metronidazole. Clinical Infectious Diseases 2010; 50:16 – 23.

Committee J. British National Formulary ( BNF) 69. London and Chicago: Pharmaceutical Press; 2015.

Bhatti A, Singh T. Preparation of tablets rapidly disintegrating in saliva containing bitter taste - masked granules by compression method. Indian J ou rnal of Pharmaceutical S ciences 2007; 69(1):80.

Pharmacopoeia US. 30/NF25. US Pharmacopoeial Convention, Rockville, MD 2013 May (Vol. 1691).

Pharmacopoeia British. Version 11.0. Appendices: XII A, XII G, XVII G. 2013.

Bharkad VB, Kada VS, Shinde SG, Jadhav SB, Zameeruddin M, Shendarkar GR. Formulation and Evaluation of Lozenges Tablet of Fluconaz ole. American Jo urnal of Pharm Research 2015; 5(01): 32071 - 32076.

Published

05-07-2019
Statistics
387 Views | 458 Downloads

How to Cite

Siham Abdoun A., and Reem Alenizi. “Formulation and Evaluation of Metronidazole Lozenges for Oral Thrush”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 6, no. 3, July 2019, pp. 05-10, doi:10.56511/JIPBS.2019.v6.i03.pp05-10.

Issue

Section

Research Article